For example, dipeptidyl-peptidase 4, a potential therapeutic for diabetic cardiomyopathy, failed to yield positive outcomes in clinical trials despite promising results shown in preclinical animal models.5,304,305. Here, DPP4 is linked to diabetic cardiomyopathy.